Table 1.
The comparison of baseline data between hospital survivors with nonsurvivors.
| Variables | Hospital nonsurvivors (n = 418) | Hospital survivors (n = 412) | P value |
|---|---|---|---|
| Male (%) | 272 (65.1) | 249 (60.4) | 0.167c |
| Age (years) | 66 (54–75) | 58 (50–71) | <0.001b |
| Weight (kg) | 64.5 (55–70) | 65 (55–70) | 0.169b |
| Hospital stay (days) | 14 (6–26) | 19 (13–31.75) | <0.001b |
| ICU stay (days) | 8 (3–16) | 8 (4–13) | 0.903b |
| Drinking history, yes (%) | 48 (11.5) | 48 (11.7) | 0.940c |
| Smoking history, yes (%) | 57 (13.6) | 49 (11.9) | 0.452c |
| Underlying disease, yes (%) | |||
| Hypertension | 156 (37.3) | 150 (36.4) | 0.785c |
| Diabetes | 90 (21.5) | 89 (21.6) | 0.980c |
| Chronic liver disease | 22 (5.3) | 25 (6.1) | 0.616c |
| Chronic kidney disease | 48 (11.5) | 31 (7.5) | 0.052c |
| Chronic respiratory disease | 30 (7.2) | 28 (6.8) | 0.830c |
| Cardiovascular disease | 93 (22.2) | 68 (16.5) | 0.036c |
| Autoimmune disease | 37 (8.9) | 27 (6.6) | 0.215c |
| Malignancy | 104 (24.9) | 49 (11.9) | <0.001c |
| Cerebrovascular disease | 76 (18.2) | 60 (14.6) | 0.222c |
| Types of underlying disease ≥ 2 | 190 (45.5) | 151 (36.7) | 0.010c |
| Use of vasoactive drugs (%) | 400 (95.7) | 321 (77.9) | <0.001c |
| Use of glucocorticoid (%) | 190 (45.5) | 98 (23.8) | <0.001c |
| Mechanical ventilation (%) | 378 (90.4) | 226 (54.9) | <0.001c |
| CRRT (%) | 179 (42.8) | 77 (18.7) | <0.001c |
| APACHE II score | 23 (19–27) | 17 (13–22) | <0.001b |
| SOFA score | 10 (8–13) | 8 (5.25–11) | <0.001b |
| GCS score | 3 (3–13) | 13.5 (3–15) | <0.001b |
a t-test and the corresponding data were expressed as mean ± SD. bNonparametric test: Mann-WhitneyU test and the corresponding data were expressed as median (interquartile range). cChi-square tests and the corresponding data were expressed as numbers (percentages). CRRT, continuous renal replacement therapy; APACHE II, acute physiology and chronic health evaluation II; SOFA, sepsis-related organ failure assessment; GCS, Glasgow coma scale.